Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
Cardiovascular Research|May 10, 2023
Monocyte heterogeneity in cardiovascular diseaseAdele V Ruder, Suzan M W Wetzels, Lieve Temmerman, et al.
Pharmacological Reviews|March 5, 2003
Interleukins in atherosclerosis: molecular pathways and therapeutic potentialJan H von der Thüsen, Johan Kuiper, Theo J C van Berkel, et al.
Thrombosis and Haemostasis|August 5, 2009
The multi-functionality of CD40L and its receptor CD40 in atherosclerosisDirk Lievens, Wouter J Eijgelaar, Erik A L Biessen, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Control of atherosclerotic plaque vulnerability: insights from transgenic miceSylvia Heeneman, Esther Lutgens, Kitty B Schapira, et al.
Cell Metabolism|June 27, 2017
Disease- or Storage-Associated Structural Modifications Are Unlikely to Explain HDL Pro-inflammatory Effects on MacrophagesEmiel P C van der Vorst, Kosta Theodorou, Erik A L Biessen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 23, 2005
Lipid emulsions potently increase transgene expression in hepatocytes after adenoviral transferJan Snoeys, Geertrui Mertens, Joke Lievens, et al.
International Journal of Molecular Sciences|September 10, 2020
MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical ApplicationLinsey J F Peters, Jürgen Floege, Erik A L Biessen, et al.
Discoveries (Craiova, Romania)|April 21, 2020
Blockade of CCR3 retains the neutrophils, preserving their survival during healing after myocardial infarctionAdelina Curaj, Mareike Staudt, Roxana Fatu, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2002
bis-Cholesteryl-conjugated phosphorothioate oligodeoxynucleotides are highly selectively taken up by the liverMartin K Bijsterbosch, Muthiah Manoharan, Rick Dorland, et al.
Pageof 17